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The EPA: DHA 6:1-evoked endothelium-dependent NO-mediated relaxa-
tion in the coronary artery involves a copper-dependent pro-oxidant res-
ponse triggering the PI3-kinase/Akt-mediated activation of eNOS
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Omega-3 fatty acid products containing eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) have been shown to reduce the risk of cardio-
vascular disease, in part, by stimulating the endothelial formation of nitric
oxide (NO), a potent vasoprotective factor. This study determined the mecha-
nism leading to endothelial NO synthase (eNOS) activation in response to the
highly active EPA:DHA 6:1 product. Vascular reactivity was assessed using
porcine coronary artery rings suspended in organ chambers, the level of oxi-
dative stress in coronary artery sections using the redox-sensitive probe, dihy-
droethidine, and the phosphorylation level of target proteins in cultured
coronary artery endothelial cells by Western blot analysis. EPA:DHA 6:1
caused pronounced endothelium-dependent relaxations in porcine coronary
artery rings. Relaxations to EPA:DHA 6:1 were slightly but significantly
reduced by an eNOS inhibitor, not affected by inhibition of endothelium-
dependent hyperpolarization and abolished by both treatments. Relaxations to
EPA:DHA 6:1 were reduced by inhibitors of oxidative stress (MnTMPyP,
PEG-catalase), an inhibitor of either Src kinase (PP2) or PI3-kinase (wort-
mannin), and intracellular copper chelating agents (neocuproine, tetrathiomo-
lybdate) and were insensitive to cyclooxygenase inhibition (indomethacin),
chelating agents for iron (desferroxamine), zinc (histidine), extracellular
copper (bathocuproine). EPA:DHA 6:1 induced phosphorylation of Src, Akt
and eNOS at Ser 1177; these effects were inhibited by MnTMPyP and PEG-
catalase. EPA:DHA 6:1 induced the endothelial formation of ROS in coronary
artery sections, this effect was inhibited by MnTMPyP, PEG-catalase, and
intracellular copper chelating agents. EPA:DHA 6:1 causes endothelium-
dependent NO-mediated relaxations in coronary artery rings, and this effect
involves an intracellular copper-dependent event triggering the redox-sensitive
PI3-kinase/Akt pathway to activate eNOS by phosphorylation at Ser 1177.
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The classic enzymatic systems that contribute to the generation of reactive
oxygen species (ROS) responsible for the development of endothelial dysfunc-
tion and neuropathy in diabetes are mitochondrial respiratory chain, NADPH
oxidases, xanthine oxidase, and uncoupled endothelial NO synthase (eNOS).
Monoamine oxidases (MAOs) are flavo-enzymes with two isoforms, A and B,
located at the outer mitochondrial membrane that constantly generate
hydrogen peroxide (H2O2) as by-product of their catalytic cycle. We have
recently shown that MAO-A and B are both expressed in the murine aorta,
induced by in vivo angiotensin II and lipopolisacharide treatment and con-
tribute via H2O2 production to endothelial dysfunction. Whether MAO-depen-
dent ROS production contributes to the development of endothelial
dysfunction in diabetes was determined here in diseased vessels obtained from
Zucker obese diabetic rats. To this aim, aortic segments with intact endothe-
lium and denuded endothelium (using CHAPS solution) were studied in
organ-bath system. The contractile response was assessed using phenylephrine
(10-8-10-6M) in the presence vs. the absence of a MAO A inhibitor, clorgy-
line (10 microM). H2O2 production was measured by a spectrophotometric
method (Feric Oxydation Xylenol Orange assay). Our data showed that MAO
inhibition reduced the diabetic-induced aortic ROS formation by 30% and par-
tially normalized the contractility of diseased vascular segments (diabetes,
41.34±2.96%, diabetes+clorgyline= 26±3.86% vs. control, 21.5±3.45%). In
conclusion, MAO-derived ROS contribute to endothelial dysfunction in the
diabetic rat. Further experiments are required to assess the mechanisms under-
lying MAO-dependent H2O2 formation.
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Although statins are the most widely used cholesterol-lowering agents for
prevention of obstructive cardiovascular events, there is a risk of myopathy
occurring in patients taking these drugs. The goal of our study was to show
that N-Acetylcystein (NAC) triggers a mitochondrial hormesis (mitohormesis)
phenomenon, able to protect the mitochondrial function from the pro-apop-
totic effects of statins. We have carried on several in vitro experiments on L6
myoblasts, and studied the effects of NAC after different exposition times.
Direct exposition of NAC at a concentration of 1mM inhibited the maximal
mitochondrial respiration and increased H2O2 production. After 24 hours of
incubation, there was an increase of the reactive oxygen species (ROS) pro-
duction measured by Electron Paramagnetic Resonance. This moderate oxida-
tive stress triggered the activation of the mitochondrial biogenesis pathways
after 24 hours of NAC incubation, as shown by RT-PCR. After one week of
exposition, ROS production was decreased compared to control, whereas the
mitochondrial content, and the maximal mitochondrial respiration were clearly
increased. At the mRNA and proteins levels our results suggested an increase
of antioxidant capacities after one week of NAC. Atorvastatin 100μM during
24H (ATO), increased ROS production, decreased the percentage of live cells,
and increased total apoptotic cells percentage. One week NAC pretreatment
decreased ROS production in presence of statins (NAC+ATO), increased the
percentage of live cells, and decreased total apoptotic cells percentage com-
pared to ATO. In conclusion, we demonstrated that NAC activates the mech-
anisms of mitochondrial biogenesis by increasing mitochondrial ROS
production, allowing to increase the metabolic power as well as the cellular
antioxidant systems The Activation of this mitohormesis phenomenon repre-
sents an interesting research field in order to protect the cells against oxidative
stress. One week NAC pretreatment protects against Statins.
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